Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Nutr ; 141(5): 863-9, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21411607

RESUMO

Chronic inflammation and proatherogenic lipids are important risk factors of cardiovascular disease (CVD). Specific dietary constituents such as polyphenols and fish oils may improve cardiovascular risk factors and may have a beneficial effect on disease outcomes. We hypothesized that the intake of an antiinflammatory dietary mixture (AIDM) containing resveratrol, lycopene, catechin, vitamins E and C, and fish oil would reduce inflammatory risk factors, proatherogenic lipids, and endpoint atherosclerosis. AIDM was evaluated in an inflammation model, male human C-reactive protein (CRP) transgenic mice, and an atherosclerosis model, female ApoE*3Leiden transgenic mice. Two groups of male human-CRP transgenic mice were fed AIDM [0.567% (wt:wt) powder and 0.933% (wt:wt oil)] or placebo for 6 wk. The effects of AIDM on basal and IL-1ß-stimulated CRP expression were investigated. AIDM reduced cytokine-induced human CRP and fibrinogen expression in human-CRP transgenic mice. In the atherosclerosis study, 2 groups of female ApoE*3Leiden transgenic mice were fed an atherogenic diet supplemented with AIDM [0.567% (wt:wt) powder and 0.933% (wt:wt oil)] or placebo for 16 wk. AIDM strongly reduced plasma cholesterol, TG, and serum amyloid A concentrations compared with placebo. Importantly, long-term treatment of ApoE*3Leiden mice with AIDM markedly reduced the development of atherosclerosis by 96% compared with placebo. The effect on atherosclerosis was paralleled by a reduced expression of the vascular inflammation markers and adhesion molecules inter-cellular adhesion molecule-1 and E-selectin. Dietary supplementation of AIDM improves lipid and inflammatory risk factors of CVD and strongly reduces atherosclerotic lesion development in female transgenic mice.


Assuntos
Antioxidantes/uso terapêutico , Aterosclerose/dietoterapia , Dieta , Óleos de Peixe/uso terapêutico , Proteínas de Fase Aguda/análise , Animais , Antioxidantes/administração & dosagem , Apolipoproteína E3/genética , Ácido Ascórbico/administração & dosagem , Ácido Ascórbico/uso terapêutico , Aterosclerose/sangue , Aterosclerose/epidemiologia , Aterosclerose/patologia , Biomarcadores/sangue , Proteína C-Reativa/análise , Proteína C-Reativa/genética , Carotenoides/administração & dosagem , Carotenoides/uso terapêutico , Catequina/administração & dosagem , Catequina/uso terapêutico , Feminino , Óleos de Peixe/administração & dosagem , Humanos , Licopeno , Masculino , Camundongos , Camundongos Transgênicos , Resveratrol , Fatores de Risco , Estilbenos/administração & dosagem , Estilbenos/uso terapêutico , Vitamina E/administração & dosagem , Vitamina E/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA